Form 4: Axogen Director William Burke Sells Shares to Cover Tax Obligations

Axogen, Inc. Director William P. Burke sold 4,073 shares of common stock for approximately $10.61 per share to satisfy tax obligations related to restricted stock unit vesting.

Summary

• William P. Burke, a Director of Axogen, Inc. (AXGN), reported a transaction on June 9, 2025.
• The transaction involved the sale of 4,073 shares of Axogen Common Stock.
• The shares were sold at a weighted average price of $10.61 per share, with prices ranging from $10.47 to $10.61.
• The purpose of the sale was to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.
• Following this transaction, Mr. Burke beneficially owns 24,484 shares of Axogen Common Stock directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine, tax-related sale of shares by a director, which is a common practice and does not typically indicate a change in company fundamentals or management's view of the company's prospects.

Positives

• The transaction is a routine sale to cover tax obligations arising from the vesting of restricted stock units, which is a common practice for executives and directors.

Negatives

• The sale by a director reduces their direct ownership stake in the company, although the reason for the sale is administrative rather than a reflection of a change in sentiment.

Risks

• No specific risks are identified or implied by this routine insider transaction report.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing is a standard insider transaction report (Form 4) and does not provide information related to broader industry trends or competitive landscape. It reflects a routine personal financial management action by a company director.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in a director's direct ownership, but given it's for tax purposes, it's unlikely to be perceived negatively or impact shareholder confidence significantly.

Key Dates

Keywords

Axogen, AXGN, Form 4, Insider Transaction, Stock Sale, Director, William Burke, Common Stock, Restricted Stock Units, Tax Obligations